arsenic has been researched along with Acute Lymphoid Leukemia in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (80.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, GQ; Duan, XF; Wang, XD; Wu, YL; Xu, HZ; Yan, H; Zhao, M; Zhuang, HY | 1 |
| Liu, XP; Narla, RK; Uckun, FM | 1 |
| Cortes, J; Kantarjian, HM; Thomas, DA | 1 |
| Hirano, T; Hu, XM; Oka, K | 1 |
| D'Cruz, OJ; Liu, XP; Narla, RK; Uckun, FM | 1 |
| Beissert, T; Güller, S; Hoelzer, D; Li, JE; Ottmann, OG; Puccetti, E; Ruthardt, M | 1 |
| Creus, A; Fortaner, S; Guillamet, E; Marcos, R; Ponti, J; Sabbioni, E | 1 |
| Bennett, JM; Dewald, GW; Gallagher, RE; Jain, V; Lee, S; Litzow, MR; Mazza, JJ; Paietta, EM; Racevskis, J; Rousey, SR; Tallman, MS | 1 |
| Bonapace, L; Bornhauser, BC; Bourquin, JP; Cario, G; Lindholm, D; Martinez, R; Niggli, FK; Schäfer, BW; Schrappe, M | 1 |
| Cockburn, M; Heck, JE; Park, AS; Qiu, J; Ritz, B | 1 |
1 review(s) available for arsenic and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
New agents in the treatment of acute lymphocytic leukaemia.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antineoplastic Agents; Arsenicals; Asparaginase; Clinical Trials as Topic; Drug Resistance, Neoplasm; Enzyme Inhibitors; Folic Acid Antagonists; Humans; Liposomes; Oligonucleotides, Antisense; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2002 |
1 trial(s) available for arsenic and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemia.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Humans; Oxides; Patient Selection; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Treatment Outcome | 2006 |
8 other study(ies) available for arsenic and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Synergistic mitosis-arresting effects of arsenic trioxide and paclitaxel on human malignant lymphocytes.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; CDC2 Protein Kinase; Cells, Cultured; Drug Synergism; Humans; Jurkat Cells; Mitosis; Oxides; Paclitaxel; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tubulin Modulators | 2010 |
Organic phenyl arsonic acid compounds with potent antileukemic activity.
Topics: Antineoplastic Agents; Arsenicals; Cell Lineage; Genes, p53; Humans; Leukemia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2003 |
Arsenic trioxide induces apoptosis equally in T lymphoblastoid leukemia MOLT-4 cells and P-gp-expressing daunorubicin-resistant MOLT-4 cells.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Division; Cell Survival; Daunorubicin; Drug Resistance, Neoplasm; Humans; Oxides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured | 2003 |
Phenylarsonic acid compounds with broad-spectrum and potent cytotoxic activity against human cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Arsenicals; Cell Division; Female; Flow Cytometry; Humans; In Situ Nick-End Labeling; Male; Microscopy, Confocal; Multiple Myeloma; Neoplasm Transplantation; Neoplasms; Ovarian Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Structure-Activity Relationship; Testicular Neoplasms; Tumor Cells, Cultured | 2003 |
Leukemia-associated translocation products able to activate RAS modify PML and render cells sensitive to arsenic-induced apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Arsenicals; Benzamides; Enzyme Inhibitors; Fibroblasts; Fusion Proteins, bcr-abl; Gene Expression Regulation, Leukemic; Genes, ras; Humans; Imatinib Mesylate; Leukemia, Promyelocytic, Acute; Monocytes; Oxides; Philadelphia Chromosome; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Isoforms; Proto-Oncogene Proteins c-abl; Pyrimidines; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Transgenes; Translocation, Genetic; Tumor Cells, Cultured; U937 Cells; Up-Regulation | 2003 |
In vitro DNA damage by arsenic compounds in a human lymphoblastoid cell line (TK6) assessed by the alkaline Comet assay.
Topics: Arsenates; Arsenicals; Comet Assay; DNA Damage; Dose-Response Relationship, Drug; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2004 |
Low-dose arsenic trioxide sensitizes glucocorticoid-resistant acute lymphoblastic leukemia cells to dexamethasone via an Akt-dependent pathway.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-Associated Death Protein; Blotting, Western; Caspases; Cell Line, Tumor; Cell Survival; Dexamethasone; Drug Resistance, Neoplasm; Drug Synergism; Glucocorticoids; Humans; Neoplasm, Residual; Oxides; Phosphorylation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Remission Induction; RNA, Small Interfering; Signal Transduction; Sirolimus; Transfection; X-Linked Inhibitor of Apoptosis Protein | 2007 |
Risk of leukemia in relation to exposure to ambient air toxics in pregnancy and early childhood.
Topics: Air Pollutants; Arsenic; Butadienes; California; Case-Control Studies; Child, Preschool; Chloroform; Environmental Exposure; Female; Humans; Hydrocarbons, Cyclic; Infant; Leukemia, Myeloid, Acute; Logistic Models; Maternal Exposure; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pregnancy; Risk Factors; Selenium; Vehicle Emissions | 2014 |